Novel quantitative software for automatically excluding red bone marrow on whole-body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study.

Yuki KohadaNozomi SataniYasuhiro KaihoHiromichi IwamuraTsuyoshi SakamotoHiroki KusumotoTakashi KukimotoMasaaki OikawaJotaro MikamiJun ItoTomonori MatsuuraNobuyuki HinataKaneki KoyamaMakoto Sato

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

Our imaging method could accurately quantify the tumor volume in patients with metastatic prostate cancer. The quantified tumor volume can be clinically applied as a new prognostic biomarker for metastatic prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
bone marrow
high resolution
squamous cell carcinoma
small cell lung cancer
data analysis
fluorescence imaging